MISONIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-11-22: Reporting owner Koby Michael; Form 4/A; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-11-22: Reporting owner Watanabe Gwendolyn A; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-11-22: Reporting owner Vizirgianakis Stavros G.; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-11-22: Reporting owner PATTON THOMAS M; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-11-22 | Koby Michael Director | 4/A | Stock Option Derivative · Indirect · By 1315 Capital Management, LLC | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $21.41 exercise price | 2019-12-06 | |
| 2019-11-22 | Watanabe Gwendolyn A Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | Vizirgianakis Stavros G. Officer (President and CEO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | PATTON THOMAS M Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | Ludecker Robert S Officer (SVP Global Sales & Marketing) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | LAVIOLETTE PAUL A Director | 4 | Stock Option Derivative · Indirect · By SV Health Investors, LLC | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | Koby Michael Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | Klugewicz Sharon W Officer (Vice President, Operations) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-11-22 | Dwyer Joseph P Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $21.41 exercise price | 2019-11-26 | |
| 2019-03-01 | Klugewicz Sharon W Officer (CHIEF OPERATING OFFICER) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $19.84 exercise price | 2019-03-05 |